Microarray analysis of laser capture microdissected substantia nigra pars compacta after a single administration of MPTP in common marmosets

Japanese Journal of Neuropsychopharmacology

Volumn 27, Issue 4, 2007, Pages 161-166

  Iwata, Shin Ichi ^a   Nomoto, Masahiro ^b   Miyata, Atsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic neuron; Microarray; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MESSENGER RNA; RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL COUNT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN GENOME; LASER CAPTURE MICRODISSECTION; MALE; MARMOSET; MICROARRAY ANALYSIS; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CALLITHRIX; CELL DEATH; DOPAMINE; DOWN-REGULATION; HUMANS; INJECTIONS, INTRAVENOUS; LASERS; MALE; MICROARRAY ANALYSIS; MICRODISSECTION; NEURONS; PARKINSON DISEASE; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 34548856202     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abramoff, M. D., Magelhaes, P. J. and Ram, S. J. (2004) Image processing with ImageJ. Biophotonics International, 11: 36-42.
2. Bassilana, F., Mace, N., Li, Q., Stutzmann, J. M., Gross, C. E., Pradier, L., Benavides, J., Menager, J. and Bezard, E. (2005) Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease. Neurobiol Dis, 20: 93-103.
3. Chen, J. Y., Hsu, P. C., Hsu, I. L. and Yeh, G. C. (2001) Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP) in C57BL/ 6 mice. Neurosci Lett, 314: 49-52.
4. Chung, C. Y., Seo, H., Sonntag, K.C., Brooks, A., Lin, L. and Isacson, O. (2005) Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet, 14: 1709-1725.
5. Duchemin, A. M., Gudehithlu, K. P., Neff, N. H. and Hadjiconstantinou, M. (1992) c-fos mRNA in mouse brain after MPTP treatment. Neurochem Int, 20: 281-287.
6. Eidelberg, E., Brooks, B. A., Morgan, W. W., Walden, J. G. and Kokemoor, R. H. (1986) Variability and functional recovery in the N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine model of parkinsonism in monkeys. Neuroscience, 18: 817-822.
7. Elsworth, J. D., Taylor, J. R., Sladek, J. R. Jr., Collier, T. J., Redmond, D. E. Jr. and Roth, R. H. (2000) Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience, 95: 399-408.
8. Fasulo, W. H. and Hemby, S. E. (2003) Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem, 87: 205-219.
9. Greene, J. G., Dingledine, R. and Greenamyre, J. T. (2005) Gene expression profiling of rat midbrain dopamine neurons: Implications for selective vulnerability in parkinsonism. Neurobiol Dis, 18: 19-31.
10. Grünblatt, E., Mandel, S., Maor, G. and Youdim, M. B. (2001) Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J Neurochem, 78: 1-12.
11. Iwata, S., Nomoto, M. and Fukuda, T. (2001) Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine. Synapse, 39: 16-22.
12. Iwata, S., Nomoto, M., Morioka, H. and Miyata, A. (2004) Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. Synapse, 51: 279-286.
13. Kurlan, R., Kim, M. H. and Gash, D. M. (1991) The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Ann Neurol, 29: 677-679.
14. Mandel, S., Grünblatt, E. and Youdim, M. (2000) cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: Implications for idiopathic Parkinson's disease. J Neural Transm Suppl, 60: 117-124.
15. Mandel, S., Grünblatt, E., Maor, G. and Youdim, M. B. (2002) Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray. Neurochem Res, 27: 1231-1243.
16. Miller, R. M., Callahan, L. M., Casaceli, C., Chen, L., Kiser, G. L., Chui, B., Kaysser-Kranich, T. M., Sendera, T. J., Palaniappan, C. and Federoff, H. J. (2004) Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci, 24: 7445-7454.
17. Nomoto, M., Iwata, S., Kaseda, S., Fukuda, T. and Nakagawa, S. (1997) Increased dopamine turnover in the putamen after MPTP treatment in common marmosets. Brain Res, 767: 235-238.
18. Nomoto, M., Kaseda, S., Iwata, S., Shimizu, T., Fukuda, T. and Nakagawa, S. (2000) The metabolic rate and vulnerability of dopaminergic neurons, and adenosine dynamics in the cerebral cortex, nucleus accumbens, caudate nucleus, and putamen of the common marmoset. J Neurol, 247 [Suppl 5]: V16-22.
19. Petzinger, G. M., Fisher, B., Hogg, E., Abernathy, A., Arevalo, P., Nixon, K. and Jakowec, M. W. (2006) Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins. J Neurosci Res, 83: 332-347.
20. Przedborski, S., Jackson-Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R. and Akram, M. (2001) The parkinsonian toxin 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety. J Neurochem, 76: 1265-1274.
21. Rose, S., Nomoto, M., Jenner, P. and Marsden, C. D. (1989a) Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochem Pharmacol, 38: 3677-3681.
22. Rose, S., Nomoto, M., Kelly, E., Kilpatrick, G., Jenner, P. and Marsden, C. D. (1989b) Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neurosci Lett, 101: 305-310.
23. Stephan, H., Baron, G. and Schwerdtfeger, W. K. (1980) The Brain of the Common Marmoset (Callithrix jacchus). Springer-Verlag, Berlin.
24. Stichel, C. C., Schoenebeck, B., Foguet, M., Siebertz, B., Bader, V., Zhu, X. R. and Lubbert, H. (2005) sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease. Eur J Neurosci, 21: 301-316.
25. Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R. Jr. and Redmond, D. E. Jr. (1997) Severe long-term 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience, 81: 745-755.